![Children | Free Full-Text | Environmental Risk Factors for Childhood Inflammatory Bowel Diseases: A Multicenter Case-Control Study Children | Free Full-Text | Environmental Risk Factors for Childhood Inflammatory Bowel Diseases: A Multicenter Case-Control Study](https://www.mdpi.com/children/children-09-00438/article_deploy/html/images/children-09-00438-ag-550.jpg)
Children | Free Full-Text | Environmental Risk Factors for Childhood Inflammatory Bowel Diseases: A Multicenter Case-Control Study
![Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study | American Society of Nephrology Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study | American Society of Nephrology](https://jasn.asnjournals.org/content/jnephrol/32/2/411/F1.large.jpg)
Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study | American Society of Nephrology
![The four epidemiological stages in the global evolution of inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology The four epidemiological stages in the global evolution of inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-020-00360-x/MediaObjects/41575_2020_360_Fig1_HTML.png)
The four epidemiological stages in the global evolution of inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology
1 Brittany Wrasman KNH 411: GI Case Study #11 Inflammatory Bowel Disease: Crohn's Disease 1. What is inflammatory bowel d
![Artificial intelligence guided discovery of a barrier-protective therapy in inflammatory bowel disease | Nature Communications Artificial intelligence guided discovery of a barrier-protective therapy in inflammatory bowel disease | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-021-24470-5/MediaObjects/41467_2021_24470_Fig1_HTML.png)
Artificial intelligence guided discovery of a barrier-protective therapy in inflammatory bowel disease | Nature Communications
![Frontiers | Reducing Disease Activity of Inflammatory Bowel Disease by Consumption of Plant-Based Foods and Nutrients Frontiers | Reducing Disease Activity of Inflammatory Bowel Disease by Consumption of Plant-Based Foods and Nutrients](https://www.frontiersin.org/files/Articles/733433/fnut-08-733433-HTML-r6/image_m/fnut-08-733433-g001.jpg)
Frontiers | Reducing Disease Activity of Inflammatory Bowel Disease by Consumption of Plant-Based Foods and Nutrients
![Increased risk of stroke among patients with inflammatory bowel disease: A PRISMA‐compliant meta‐analysis - Chen - 2021 - Brain and Behavior - Wiley Online Library Increased risk of stroke among patients with inflammatory bowel disease: A PRISMA‐compliant meta‐analysis - Chen - 2021 - Brain and Behavior - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6f6d72be-37a5-41da-a1f5-6c4f0ca6129d/brb32159-fig-0001-m.jpg)
Increased risk of stroke among patients with inflammatory bowel disease: A PRISMA‐compliant meta‐analysis - Chen - 2021 - Brain and Behavior - Wiley Online Library
![Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis - The Lancet Gastroenterology & Hepatology Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/79aaf736-ee6a-493c-a73b-3d05e4cd7a57/gr1.gif)
Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis - The Lancet Gastroenterology & Hepatology
![PPT – Inflammatory Bowel Disease Case Study PowerPoint presentation | free to view - id: 100873-MDkwM PPT – Inflammatory Bowel Disease Case Study PowerPoint presentation | free to view - id: 100873-MDkwM](https://s3.amazonaws.com/images.powershow.com/P1254413617zYVNj.pr.jpg)
PPT – Inflammatory Bowel Disease Case Study PowerPoint presentation | free to view - id: 100873-MDkwM
![Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden - The Lancet Gastroenterology & Hepatology Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/asset/6340547a-f6a4-440d-9c1d-a1cea2e33706/gr1.gif)
Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden - The Lancet Gastroenterology & Hepatology
![Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study - The Lancet Gastroenterology & Hepatology Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/asset/5b6d5da4-6393-47a3-922d-09bb3ed03eae/gr1.jpg)